EMERGENT BIOSOLUTIONS INC Performance

29089QAC9   84.50  0.33  0.39%   
The bond shows a Beta (market volatility) of 0.0445, which means not very significant fluctuations relative to the market. As returns on the market increase, EMERGENT's returns are expected to increase less than the market. However, during the bear market, the loss of holding EMERGENT is expected to be smaller as well.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in EMERGENT BIOSOLUTIONS INC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, EMERGENT is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Yield To Maturity25.220
  

EMERGENT Relative Risk vs. Return Landscape

If you would invest  8,375  in EMERGENT BIOSOLUTIONS INC on November 9, 2024 and sell it today you would earn a total of  75.00  from holding EMERGENT BIOSOLUTIONS INC or generate 0.9% return on investment over 90 days. EMERGENT BIOSOLUTIONS INC is generating 0.0209% of daily returns and assumes 0.8753% volatility on return distribution over the 90 days horizon. Simply put, 7% of bonds are less volatile than EMERGENT, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon EMERGENT is expected to generate 1.22 times more return on investment than the market. However, the company is 1.22 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.03 per unit of risk.

EMERGENT Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for EMERGENT's investment risk. Standard deviation is the most common way to measure market volatility of bonds, such as EMERGENT BIOSOLUTIONS INC, and traders can use it to determine the average amount a EMERGENT's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0239

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns29089QAC9

Estimated Market Risk

 0.88
  actual daily
7
93% of assets are more volatile

Expected Return

 0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average EMERGENT is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EMERGENT by adding it to a well-diversified portfolio.

About EMERGENT Performance

By analyzing EMERGENT's fundamental ratios, stakeholders can gain valuable insights into EMERGENT's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if EMERGENT has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if EMERGENT has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.